Truqap is really a kinase inhibitor that actually works by blocking pathways that enable the cancer cells endure and improve, so lessens cancer growth. Truqap is from a class of medicines called an AKT inhibitor. Truqap been given FDA approval on November seventeen, 2023, soon after constructive fin